J&J Unit Keeps Generic Cos. At Bay Over Risperdal
Blocking two proposed generic versions of an antipsychotic drug, a New Jersey district court has affirmed the validity and enforceability of a Johnson & Johnson unit's patent for Risperdal....To view the full article, register now.
Already a subscriber? Click here to view full article